89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 239
- Type
- D - Journal article
- DOI
-
10.1158/1078-0432.CCR-14-0491
- Title of journal
- Clin Cancer Res
- Article number
- -
- First page
- 3945
- Volume
- 20
- Issue
- 15
- ISSN
- 1557-3265
- Open access status
- Out of scope for open access requirements
- Month of publication
- July
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
https://clincancerres.aacrjournals.org/content/20/15/3945.figures-only
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
12
- Research group(s)
-
-
- Citation count
- 72
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
